mTOR inhibitor

Businessman climbing steps to pluck a star from the sky
Biotech

Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 study

A phase 3 trial of Celcuity’s pan-PI3K/mTOR inhibitor has hit its primary endpoint, clearing the biotech to file a second submission for the molecule.
Nick Paul Taylor May 4, 2026 8:06am
Graphic of an open door with the words exit above it

Leaked Whitehead report details Sabatini accusations, findings

Dec 22, 2022 9:24am
Parachute

Gilead's Immunomedics CMO exits to Aadi as it nears FDA decision

Oct 25, 2021 9:26am
Breast cancer metastasis to liver

Shutting down cancer cell 'highways' by blocking a protein

Oct 29, 2019 8:14am
Liver tissue on scaffold

Anti-rejection drug rapamycin shows promise in liver cancer

Feb 1, 2019 12:26pm
Cancer in newspaper clipping

New insight into why malaria drugs work against some cancers

Nov 16, 2018 10:45am